United Therapeutics launches $250m share repurchase program

United Therapeutics (NSDQ:UTHR) said today that its board of directors approved the repurchase of up to $250 million of the biotech’s common stock.

The share repurchase program is effective immediately and United said it will stay open until the end of 2017. The company can make purchases in the open market, accelerated share repurchases or in privately negotiated transactions.

Get the full story at our sister site, Drug Delivery Business News.

The post United Therapeutics launches $250m share repurchase program appeared first on MassDevice.

from MassDevice http://ift.tt/2oEbzSS